Skip to content
★ Sign in to follow
DS

Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Botanix Pharmaceuticals Ltd
Total declarations
1
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 18 Oct 2026 for Botanix Pharmaceuticals Ltd.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust: trading record in brief

One trade, one date: on 18 October 2026, Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust disclosed a transaction in Botanix Pharmaceuticals Ltd. No broader history exists yet. Source: insider filings from ASX. Past trades are no guide to future returns.

Companies and markets linked to Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total

1 of 1 declaration